Autistic Disorder
|
0.340 |
AlteredExpression
|
disease |
BEFREE |
Constitutional downregulation of SEMA5A expression in autism.
|
17028446 |
2006 |
Autistic Disorder
|
0.340 |
Biomarker
|
disease |
BEFREE |
We also demonstrated that expression of SEMA5A is reduced in brains from autistic patients, further implicating SEMA5A as an autism susceptibility gene.
|
19812673 |
2009 |
Autistic Disorder
|
0.340 |
Biomarker
|
disease |
CTD_human |
Constitutional downregulation of SEMA5A expression in autism.
|
17028446 |
2006 |
Autistic Disorder
|
0.340 |
Biomarker
|
disease |
BEFREE |
This study supports newly recognized effects of aberrant SEMA5A and CTNND2 dosage on severity of autistic and cognitive phenotypes.
|
26601658 |
2016 |
Autistic Disorder
|
0.340 |
Biomarker
|
disease |
LHGDN |
Constitutional downregulation of SEMA5A expression in autism.
|
17028446 |
2006 |
Autistic Disorder
|
0.340 |
Biomarker
|
disease |
BEFREE |
We take a step towards better understanding of the significance of SEMA5A pathways in autism that can guide interpretation of many other genetic results in ASDs.
|
23575222 |
2013 |
Alcoholic Intoxication, Chronic
|
0.310 |
Biomarker
|
disease |
BEFREE |
In addition, ALK, CASC4, and SEMA5A were strongly associated with alcohol dependence (p<2 × 10(-5)) in the meta-analysis.
|
21703634 |
2011 |
Alcoholic Intoxication, Chronic
|
0.310 |
Biomarker
|
disease |
PSYGENET |
In addition, ALK, CASC4, and SEMA5A were strongly associated with alcohol dependence (p<2 × 10(-5)) in the meta-analysis.
|
21703634 |
2011 |
Cri-du-Chat Syndrome
|
0.310 |
GeneticVariation
|
disease |
ORPHANET |
|
|
|
Cri-du-Chat Syndrome
|
0.310 |
GeneticVariation
|
disease |
BEFREE |
Two genes, Semaphorin F (SEMAF) and delta-catenin (CTNND2), which have been mapped to the "critical regions", are potentially involved in cerebral development and their deletion may be associated with mental retardation in CdCS patients.
|
16953888 |
2006 |
Monosomy 5p
|
0.300 |
GeneticVariation
|
disease |
ORPHANET |
|
|
|
Dwarfism
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Leukemia, Myelocytic, Acute
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-wide haplotype association study identify the FGFR2 gene as a risk gene for acute myeloid leukemia.
|
27903959 |
2017 |
Microcephaly
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Myasthenia Gravis
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Genome-Wide Association Study of Late-Onset Myasthenia Gravis: Confirmation of TNFRSF11A and Identification of ZBTB10 and Three Distinct HLA Associations.
|
26562150 |
2016 |
Scoliosis, unspecified
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Severe intellectual disability
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Syndactyly of fingers
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Byzanthine arch palate
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Childhood asthma
|
0.100 |
GeneticVariation
|
disease |
GWASDB |
Rank-based genome-wide analysis reveals the association of ryanodine receptor-2 gene variants with childhood asthma among human populations.
|
23829686 |
2013 |
Congenital Epicanthus
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease.
|
29212778 |
2018 |
Abnormality of bone mineral density
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Abnormality of cardiovascular system morphology
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Pancreatic carcinoma
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Our earlier reports demonstrated that membrane-bound semaphorin 5A (SEMA5A) is expressed in aggressive pancreatic cancer cells and tumours, and promotes tumour growth and metastasis.
|
22782341 |
2012 |